(Reuters) - FDA has approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States. The U.S. Food...
(Reuters) - FDA has approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States. The U.S. Food...
(Reuters) - The board of directors of Vivus Inc is under attack from one of its biggest investors following the disappointing launch of a diet pill that has helped drive...
(Reuters) - Growing evidence of a link between GlaxoSmithKline Plc's pandemic flu vaccine and an increase in narcolepsy cases among children who received it in Europe, is giving pause to...
(Reuters) - Growing evidence of a link between GlaxoSmithKline Plc's pandemic flu vaccine and an increase in narcolepsy cases among children who received it in Europe, is giving pause to...
WASHINGTON (Reuters) - The Food and Drug Administration kicked off a series of public meetings on Thursday to explain its proposed new rules for improving the safety of the nation's...
WASHINGTON (Reuters) - U.S. health regulators approved a new drug made by Swiss drugmaker Roche Holding AG for some patients with late-stage metastatic breast cancer who fail to respond to...
WASHINGTON (Reuters) - U.S. health regulators approved a new drug made by Swiss drugmaker Roche Holding AG for some patients with late-stage metastatic breast cancer who fail to respond to...
WASHINGTON (Reuters) - Four years after a salmonella outbreak linked to tainted peanut butter sickened hundreds in the United States and killed nine, authorities have charged the former owner of...
(Reuters) - U.S. regulators have approved a new drug from Celgene Corp for patients with multiple myeloma whose disease has worsened after being treated with other cancer drugs. The U.S....